Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Kemadrin (procyclidine hydrochloride) is a prescription medication used to relieve certain movement-related symptoms associated with Parkinson’s disease and medication-induced movement disorders.
Kemadrin contains procyclidine hydrochloride, an active ingredient belonging to a class of medications called anticholinergics, also known as antimuscarinic agents.
Anticholinergic medications work by blocking the effects of acetylcholine, a natural chemical messenger that helps regulate muscle movement and other functions throughout the body.
In people with Parkinson’s disease, an imbalance between dopamine and acetylcholine activity can contribute to symptoms such as muscle stiffness, tremors, and difficulty moving.
Kemadrin helps reduce excessive acetylcholine activity in certain areas of the brain, which may improve muscle control and relieve some movement-related symptoms.
The medication is available as oral tablets, commonly containing 5 mg of procyclidine hydrochloride.
Kemadrin is primarily used for two conditions:
Your healthcare provider will determine whether Kemadrin is appropriate based on your symptoms, age, medical history, and other medications.
Kemadrin is used to help manage certain symptoms of Parkinson’s disease, a progressive neurological condition that affects movement and muscle coordination.
Parkinson’s disease develops when nerve cells in a region of the brain called the substantia nigra become damaged or gradually stop functioning.
These nerve cells produce dopamine, an important chemical messenger involved in controlling movement.
Dopamine helps the brain coordinate smooth, controlled muscle movements.
When dopamine levels decrease, the balance between dopamine and acetylcholine activity becomes disrupted.
This imbalance contributes to several movement-related symptoms associated with Parkinson’s disease.
Common symptoms include:
Kemadrin helps relieve certain symptoms by reducing the effects of acetylcholine in the brain.
This may improve muscle stiffness, tremors, and certain movement difficulties.
However, its effectiveness varies depending on the individual and the symptoms being treated.
Muscle rigidity is one of the main symptoms of Parkinson’s disease.
It occurs when muscles remain unusually stiff, making it difficult to move the arms, legs, neck, or other parts of the body.
Some people experience discomfort, reduced flexibility, or difficulty performing activities such as dressing, walking, and getting out of a chair.
Kemadrin helps reduce excessive acetylcholine activity involved in muscle control.
This may help relieve stiffness and allow muscles to move more comfortably.
For some patients, reducing rigidity can improve coordination and make daily activities easier.
Tremors are involuntary shaking movements that commonly affect people with Parkinson’s disease.
They often begin in one hand or arm and may become more noticeable when the affected body part is resting.
Tremors can interfere with everyday activities such as eating, writing, holding objects, or getting dressed.
Kemadrin may help reduce certain Parkinson’s-related tremors by restoring some balance between acetylcholine and dopamine activity.
However, not everyone experiences the same level of improvement.
Some patients may benefit more from medications that directly support dopamine activity.
Your healthcare provider will consider your symptoms when selecting the most appropriate treatment.
Parkinson’s disease can make everyday movements slower and more difficult.
This symptom is called bradykinesia.
People with bradykinesia may have difficulty starting movements, walking normally, or performing tasks that require precise coordination.
Kemadrin may provide some improvement in movement-related symptoms, particularly when muscle rigidity contributes to these difficulties.
However, Kemadrin is generally less effective for bradykinesia than medications that directly increase or replace dopamine activity, such as levodopa.
For this reason, Kemadrin is not usually the preferred first-line treatment for most people with Parkinson’s disease.
It may be prescribed alone in selected patients or combined with other Parkinson’s medications when additional symptom control is needed.
Kemadrin is also used to manage certain movement-related side effects caused by antipsychotic medications.
These side effects are called extrapyramidal symptoms (EPS).
Extrapyramidal symptoms develop when medications interfere with dopamine signaling in brain regions involved in movement control.
Certain antipsychotic medications block dopamine receptors to produce their intended effects.
However, dopamine also plays an important role in regulating muscle movements.
When dopamine activity becomes reduced, acetylcholine activity may become relatively more prominent, contributing to abnormal muscle movements or stiffness.
Kemadrin helps reduce these symptoms by blocking muscarinic acetylcholine receptors.
Drug-induced movement problems that may respond to Kemadrin include medication-induced parkinsonism, acute dystonia, and certain cases of akathisia.
Drug-induced parkinsonism occurs when certain medications cause movement symptoms resembling those of Parkinson’s disease.
These symptoms may develop after starting a dopamine-blocking medication or increasing its dosage.
Common symptoms include:
Kemadrin helps manage drug-induced parkinsonism by reducing acetylcholine activity and improving the balance of movement-related chemical signals.
This may relieve muscle stiffness, tremors, and other symptoms.
Your healthcare provider may also consider adjusting the medication responsible for the movement disorder.
Do not stop taking prescribed medications without medical advice.
Acute dystonia is a movement disorder that causes sudden, involuntary muscle contractions.
These contractions may cause painful muscle spasms or force certain parts of the body into unusual positions.
Acute dystonic reactions can occur after starting certain antipsychotic medications or increasing their dosage.
Possible symptoms include:
Kemadrin may help relieve acute dystonic symptoms by blocking acetylcholine activity involved in abnormal muscle contractions.
Severe acute dystonia, particularly when it affects breathing or swallowing, requires emergency medical treatment.
Akathisia is a movement-related side effect that causes intense restlessness and difficulty remaining still.
People with akathisia may feel an overwhelming need to move.
Possible symptoms include:
Akathisia may develop after starting or increasing certain medications, particularly antipsychotics.
Kemadrin has been used to manage some cases of medication-induced akathisia.
However, anticholinergic medications are not consistently effective for akathisia, especially when muscle stiffness or other parkinsonian symptoms are absent.
Your healthcare provider may recommend other treatment approaches depending on the cause and severity of the symptoms.
Kemadrin is not recommended for treating tardive dyskinesia.
Tardive dyskinesia is a movement disorder that may develop after prolonged exposure to certain dopamine-blocking medications.
It causes repetitive, involuntary movements, particularly involving the face, mouth, lips, and tongue.
Symptoms may include lip smacking, repetitive chewing movements, tongue protrusion, or involuntary movements of the arms and legs.
Although Kemadrin may help some other medication-induced movement disorders, it does not reliably improve tardive dyskinesia.
In some patients, anticholinergic medications such as procyclidine may make tardive dyskinesia symptoms worse.
Your healthcare provider will determine the type of movement disorder before recommending treatment.Â
Kemadrin contains procyclidine hydrochloride, an anticholinergic medication that blocks certain muscarinic acetylcholine receptors.
Acetylcholine is a neurotransmitter, or chemical messenger, that helps nerve cells communicate with muscles and other tissues.
In the brain, acetylcholine works alongside dopamine to help regulate movement and muscle coordination.
When dopamine activity decreases, as occurs in Parkinson’s disease or during treatment with certain dopamine-blocking medications, acetylcholine activity may become relatively dominant.
This imbalance can contribute to tremors, muscle stiffness, and other movement difficulties.
Kemadrin helps reduce these effects by blocking acetylcholine activity at muscarinic receptors.
Blocks Muscarinic Acetylcholine Receptors
Muscarinic receptors are proteins found in the nervous system and several organs throughout the body.
When acetylcholine attaches to these receptors, it activates signals involved in muscle movement and other functions.
Procyclidine prevents acetylcholine from activating certain muscarinic receptors.
This reduces excessive cholinergic signalling in areas of the brain involved in movement regulation.
The result may be less muscle stiffness, reduced tremors, and improved movement control in selected patients.
Helps Restore Movement-Related Chemical Balance
Normal muscle movement depends on coordinated signalling between several neurotransmitters, including dopamine and acetylcholine.
In Parkinson’s disease, reduced dopamine activity disrupts this balance.
Kemadrin does not replace missing dopamine or stop the underlying loss of dopamine-producing nerve cells.
Instead, it reduces acetylcholine activity, helping compensate for part of the chemical imbalance.
This may relieve certain symptoms, particularly muscle rigidity and tremors.
Reduces Medication-Induced Muscle Spasms
Some antipsychotic medications reduce dopamine activity in brain pathways that control muscle movement.
This can cause involuntary muscle contractions, stiffness, or abnormal postures.
Kemadrin reduces the effects of acetylcholine in these movement pathways.
This may help relieve certain drug-induced symptoms, including acute dystonia and medication-induced parkinsonism.
However, its effectiveness depends on the type of movement disorder.
Kemadrin begins acting after the medication is absorbed into the bloodstream.
Some patients may experience symptom improvement within a few hours after taking an oral dose.
However, the time needed to achieve noticeable benefits depends on the condition being treated, symptom severity, and prescribed dosage.
For Parkinson’s disease, your healthcare provider may gradually adjust the dosage over several days until an appropriate response is achieved.
For drug-induced extrapyramidal symptoms, improvement may occur more quickly, particularly when the medication is used to treat certain muscle spasms.
Kemadrin is usually started at a low dose and increased gradually to reduce the risk of side effects.
The recommended dosing schedule varies according to the condition being treated and individual response.
Do not increase your dosage if you do not notice immediate improvement.
Kemadrin may cause anticholinergic side effects because acetylcholine also controls functions outside the brain.
Common side effects include dry mouth, blurred vision, constipation, dizziness, and difficulty urinating.
Some people, particularly older adults, may experience confusion or memory difficulties.
Kemadrin should not be used by people with certain conditions, including untreated urinary retention, angle-closure glaucoma, or gastrointestinal obstruction.
Tell your healthcare provider if you have an enlarged prostate, heart disease, liver or kidney problems, or a history of glaucoma.
Do not stop taking Kemadrin suddenly without medical advice, as Parkinson’s-related symptoms may return or worsen.
Kemadrin helps relieve certain symptoms of Parkinson’s disease and medication-induced movement disorders by blocking acetylcholine activity. It may improve muscle rigidity, tremors, and acute muscle spasms, but it does not cure Parkinson’s disease or treat every type of abnormal movement.
Kemadrin is a prescription medication used to relieve certain symptoms of Parkinson’s disease and movement-related side effects caused by certain medications, particularly antipsychotic drugs.
Kemadrin belongs to a class of medications called anticholinergics. It works by blocking the effects of acetylcholine, a chemical messenger involved in muscle movement and coordination.
By reducing acetylcholine activity, Kemadrin may help relieve muscle stiffness, tremors, and certain involuntary muscle contractions.
Kemadrin is available as a 5 mg oral tablet. It is generally taken three times daily, with a possible fourth dose at bedtime, depending on your medical condition and prescribed dosage.
Your healthcare provider will determine the appropriate dose based on your symptoms, age, response to treatment, and other medications.
Follow these steps to take Kemadrin correctly and safely:
Continue following your healthcare provider’s instructions throughout treatment.
The recommended dosage depends on the condition being treated and your individual response.
Your healthcare provider may gradually increase the dosage until your symptoms improve without causing unacceptable side effects.
| Condition | General adult dosage |
| Parkinson’s disease | Usually starts at 2.5 mg three times daily |
| Parkinson’s maintenance treatment | Commonly 15–30 mg daily in divided doses |
| Drug-induced extrapyramidal symptoms | Usually starts at 2.5 mg three times daily |
| Maintenance for drug-induced symptoms | Commonly 10–30 mg daily in divided doses |
| Additional bedtime dose | May be prescribed when necessary |
For Parkinson’s disease, the starting dose may be increased by 2.5–5 mg per day at intervals of two or three days until an appropriate response is achieved.
For medication-induced movement disorders, the dosage may be increased gradually according to symptom control and tolerability.
Higher doses are occasionally prescribed under specialist supervision, but they are not appropriate for everyone.
Older adults may require lower doses because they are more sensitive to anticholinergic side effects, including confusion, dizziness, and memory problems.
These dosage ranges are general prescribing information, not instructions to adjust your medication. Always follow your individual prescription.Â
Taking Kemadrin consistently helps maintain its effects on movement-related symptoms.
Parkinson’s disease affects the brain’s ability to control smooth and coordinated muscle movements.
Reduced dopamine activity creates an imbalance between dopamine and acetylcholine, contributing to symptoms such as tremors and muscle rigidity.
Kemadrin helps reduce excessive acetylcholine activity, which may improve certain movement symptoms.
Taking the medication regularly according to your prescribed schedule helps maintain symptom control throughout the day.
If you frequently miss doses, you may notice a return or worsening of muscle stiffness, tremors, or involuntary movements.
Try to take Kemadrin at approximately the same times each day.
If you have difficulty remembering your medication, consider setting reminders or using a medication schedule.
Yes, Kemadrin can generally be taken with or without food.
However, some patients experience nausea or stomach discomfort when taking anticholinergic medications.
Taking Kemadrin during or after a meal may help reduce these symptoms.
For example, if your healthcare provider prescribes Kemadrin three times daily, you may take it after breakfast, lunch, and dinner.
If an additional bedtime dose is prescribed, take it according to your healthcare provider’s instructions.
Kemadrin tablets should be swallowed with water. The scored 5 mg tablet can be divided into equal halves when prescribed.
If you experience persistent nausea, abdominal discomfort, or other digestive problems, contact your healthcare provider.
Kemadrin may interact with other medications, particularly those that affect acetylcholine activity or movement control.
Because Kemadrin is an anticholinergic medication, combining it with other drugs that have similar effects may increase the risk of side effects.
Important interactions include:
Antacids and Antidiarrheal Medications
Tell your healthcare provider or pharmacist if you regularly take antacids containing magnesium, aluminum, or calcium.
Some antacids and adsorbent antidiarrheal medications, such as products containing kaolin or attapulgite, may affect the absorption of certain oral medications.
However, a specific mandatory separation interval between Kemadrin and these products is not established in the current Kemadrin product information.
Your pharmacist can determine whether your medications need to be taken at different times.
Do not automatically change your dosing schedule without checking the instructions for the products you use.
Ketoconazole
Ketoconazole is an antifungal medication used to treat certain fungal infections.
Because anticholinergic medications may slow stomach emptying, they can sometimes affect how other oral medications are absorbed.
If you take oral ketoconazole, tell your healthcare provider or pharmacist before starting Kemadrin.
Some ketoconazole products have specific administration requirements and important interactions with other medications.
Your pharmacist can advise whether you need to separate the doses or use an alternative treatment.
Levodopa and Other Parkinson’s Medications
Kemadrin may be prescribed alongside levodopa or other medications used to treat Parkinson’s disease.
Levodopa helps increase dopamine activity in the brain, while Kemadrin reduces acetylcholine activity.
These medications work through different mechanisms to improve movement control.
However, anticholinergic medications can slow stomach emptying, which may affect levodopa absorption and response.
Your healthcare provider may adjust one or both medications to improve symptom control and reduce side effects.
Do not change your levodopa dosage or other Parkinson’s medications without medical advice.
Other Anticholinergic Medications
Combining Kemadrin with other anticholinergic medications may increase the risk of dry mouth, constipation, blurred vision, urinary retention, and confusion.
These may include certain antihistamines, antidepressants, bladder medications, and medications used for movement disorders.
Tell your healthcare provider about all medications you take so that possible interactions can be reviewed.Â
Kemadrin may be prescribed to relieve certain extrapyramidal symptoms caused by antipsychotic medications.
Extrapyramidal symptoms are movement-related side effects that may include muscle stiffness, tremors, slowed movements, and involuntary muscle contractions.
These symptoms occur when certain medications interfere with dopamine signaling in areas of the brain involved in movement.
Kemadrin helps relieve selected symptoms by reducing acetylcholine activity.
Your healthcare provider may recommend regular dosing while the symptoms are present.
Treatment duration depends on the medication causing the symptoms, their severity, and your response.
In some patients, Kemadrin may be reduced or discontinued after several months to determine whether the movement-related side effects have resolved.
Do not stop taking the medication responsible for the movement disorder without consulting your healthcare provider.
Your healthcare provider may adjust the original medication, change its dosage, or recommend a different treatment.
If you forget to take Kemadrin, follow the missed-dose instructions provided with your prescription.
Generally, you may take the missed dose when you remember, unless it is almost time for your next scheduled dose.
If your next dose is approaching, skip the missed dose and continue with your regular schedule.
Do not take two doses together to make up for a missed dose.
Taking more Kemadrin than prescribed may increase the risk of serious anticholinergic side effects.
These may include confusion, hallucinations, rapid heartbeat, severe constipation, and difficulty urinating.
If you miss several doses or are unsure when to restart treatment, contact your healthcare provider or pharmacist.
Do not stop taking Kemadrin suddenly without consulting your healthcare provider.
Kemadrin helps manage movement-related symptoms by reducing acetylcholine activity in the brain.
If treatment is stopped abruptly, Parkinson’s-related symptoms may return or become worse.
Patients taking Kemadrin for medication-induced movement disorders may also experience a return of muscle stiffness, tremors, or involuntary muscle contractions.
Your healthcare provider may recommend gradually reducing the dosage before discontinuing treatment.
The appropriate withdrawal schedule depends on your current dosage, treatment duration, and medical condition.
Kemadrin has the potential for misuse because some individuals may experience mood-altering effects when taking higher-than-prescribed doses.
Although reports of misuse are relatively uncommon, the risk may be higher in people with a history of substance misuse.
Taking excessive amounts may cause serious side effects, including confusion, hallucinations, agitation, and an abnormally fast heartbeat.
Do not take Kemadrin more frequently, in larger amounts, or for longer than prescribed.
If you feel unable to control your medication use, contact your healthcare provider for guidance.
Contact your healthcare provider if you experience worsening tremors, increased muscle stiffness, persistent dizziness, blurred vision, constipation, or difficulty urinating.
Kemadrin may also cause confusion, memory problems, or hallucinations, particularly in older adults and people taking higher doses.
Tell your healthcare provider if your symptoms are not improving or if you develop side effects that interfere with your daily activities.
Seek urgent medical attention if you experience severe confusion, an unusually rapid heartbeat, inability to urinate, or signs of a serious medication reaction.
Kemadrin helps manage certain symptoms of Parkinson’s disease and medication-induced movement disorders when taken according to your prescribed schedule. Starting with an appropriate dose, monitoring your response, reviewing medication interactions, and avoiding abrupt discontinuation can help support safer treatment.
Kemadrin (procyclidine) is available in the following forms and strength:
Before taking Kemadrin, tell your healthcare provider about any medical conditions, allergies, or medications you are taking.
Kemadrin is a prescription medication used to manage certain symptoms of Parkinson’s disease and movement-related side effects caused by some medications, particularly antipsychotic drugs.
Kemadrin belongs to a class of medications called anticholinergics, also known as antimuscarinic agents. It works by blocking the effects of acetylcholine, a chemical messenger involved in muscle movement and other body functions.
By reducing acetylcholine activity in certain parts of the brain, Kemadrin may help relieve tremors, muscle stiffness, and involuntary muscle contractions.
However, acetylcholine also helps regulate digestion, urination, vision, sweating, and heart rate. Blocking its effects may cause side effects involving these functions.
Your healthcare provider will assess your medical history to determine whether Kemadrin is appropriate for you.
Do not take Kemadrin if you have a known allergy to procyclidine hydrochloride or any other ingredient in the medication.
An allergic reaction occurs when the immune system responds abnormally to a substance that is usually harmless.
Allergic reactions may range from mild skin symptoms to severe, potentially life-threatening reactions.
Possible symptoms include:
Tell your healthcare provider if you have experienced allergic reactions to Kemadrin or other medications in the past.
If you develop a rash, unusual itching, or swelling after taking Kemadrin, stop taking the medication and seek medical advice promptly.
Seek emergency medical attention immediately if you experience difficulty breathing, swelling of the tongue or throat, or symptoms of anaphylaxis.
Kemadrin should be used with caution in people with heart disease or certain cardiovascular conditions.
Procyclidine blocks muscarinic receptors involved in regulating several body functions, including heart rate.
As a result, Kemadrin may increase the heart rate in some individuals.
This effect may be more concerning for people who already have a rapid heartbeat, abnormal heart rhythm, or another significant cardiovascular condition.
Possible symptoms include:
Tell your healthcare provider if you have coronary artery disease, heart failure, a history of heart attack, or an abnormal heart rhythm.
Your healthcare provider may recommend monitoring your heart rate and adjusting your treatment if necessary.
Contact your healthcare provider if you experience persistent palpitations or an unusually fast heartbeat.
Seek emergency medical attention if you develop severe chest pain, fainting, or significant breathing difficulties.
Kemadrin may increase pressure inside the eyes and should be used with caution in people with certain eye conditions.
The medication blocks acetylcholine activity, which can cause the pupils to become larger.
Pupil dilation may interfere with normal fluid drainage in people who have narrow drainage angles inside their eyes.
This can cause a sudden increase in intraocular pressure, potentially triggering acute angle-closure glaucoma.
Angle-closure glaucoma is a serious eye condition that can cause permanent vision loss if it is not treated promptly.
Possible symptoms include:
Kemadrin must not be used by people with untreated angle-closure glaucoma.
If you have open-angle glaucoma or another eye condition, tell your healthcare provider before starting Kemadrin.
Your healthcare provider may recommend monitoring your eye pressure or choosing another treatment.
Seek emergency medical attention if you experience sudden severe eye pain, rapid vision changes, or a headache accompanied by nausea and eye redness.
Kemadrin should not be used by people with certain serious gastrointestinal conditions, including mechanical bowel obstruction.
Procyclidine reduces acetylcholine activity, which can slow normal muscle contractions in the digestive tract.
These contractions, called peristalsis, help move food and waste through the stomach and intestines.
When gastrointestinal movement slows, constipation and abdominal discomfort may develop.
In people with an existing bowel obstruction, reducing intestinal movement can make the condition more dangerous.
Possible symptoms of gastrointestinal problems include:
Tell your healthcare provider if you have chronic constipation, a history of bowel obstruction, or another condition affecting intestinal movement.
Kemadrin may also be unsuitable for people with certain conditions that involve reduced gastrointestinal motility.
Contact your healthcare provider if constipation becomes persistent or uncomfortable.
Seek urgent medical attention if you develop severe abdominal pain, repeated vomiting, significant abdominal swelling, or an inability to pass stool or gas.
Kemadrin may cause difficulty urinating because it blocks acetylcholine activity in the urinary system.
Normally, acetylcholine helps the bladder muscle contract so urine can be released.
When its effects are reduced, the bladder may have difficulty emptying completely.
This may cause urinary retention, a condition in which urine remains inside the bladder.
People with an enlarged prostate or an existing urinary obstruction may be particularly susceptible.
Possible symptoms include:
Kemadrin should not be used by people with urinary retention unless a specialist has determined an appropriate treatment approach consistent with the product’s contraindications.
Tell your healthcare provider if you have an enlarged prostate, bladder problems, or a history of urinary retention.
Seek urgent medical attention if you are unable to urinate, particularly if you develop lower abdominal pain or swelling.
Kemadrin may interact with other medications, especially those that have anticholinergic effects.
Combining several medications that block acetylcholine may increase the risk of dry mouth, constipation, blurred vision, urinary retention, confusion, and overheating.
Important interactions include:
Tell your healthcare provider about all prescription medications, over-the-counter products, vitamins, and herbal supplements you take.
Your healthcare provider or pharmacist can review possible interactions and determine whether medication adjustments are necessary.
Do not start, stop, or combine medications without medical advice.
Kemadrin may cause side effects involving the central nervous system, particularly when taken at higher doses.
Acetylcholine helps regulate memory, attention, and other brain functions. Because Kemadrin blocks certain acetylcholine receptors, it may affect how clearly you think or remember information.
Possible symptoms include:
Older adults may be more sensitive to these effects, particularly when taking higher doses.
Mild side effects may improve after your healthcare provider adjusts the dosage. However, new confusion, memory problems, or hallucinations should not be ignored.
Contact your healthcare provider promptly if you notice changes in your thinking, memory, or behavior.
Seek urgent medical attention if you develop severe confusion, significant agitation, or sudden changes in awareness.Â
Kemadrin should be used with caution in people with certain psychiatric conditions, particularly those with a history of psychosis.
Procyclidine affects chemical signalling in the brain, which may sometimes cause changes in mood, thinking, and behaviour.
Some patients have reported anxiety, nervousness, agitation, confusion, and hallucinations during treatment.
Rarely, Kemadrin may trigger or worsen psychotic symptoms in susceptible individuals.
Psychosis is a condition in which a person may have difficulty distinguishing between what is real and what is not.
Possible symptoms include:
Tell your healthcare provider if you have a history of psychosis, anxiety, or depression before taking Kemadrin.
Depression is not a well-established common side effect of Kemadrin. However, changes in mood or behavior should still be discussed with your healthcare provider.
People taking Kemadrin to manage antipsychotic-related movement symptoms may require particularly careful monitoring.
Your healthcare provider may adjust your treatment if psychiatric symptoms develop or worsen.
Do not stop Kemadrin or your prescribed antipsychotic medication without medical advice.Â
Kemadrin may cause dizziness, blurred vision, confusion, or reduced alertness in some individuals.
These side effects can interfere with activities that require clear vision, concentration, and coordination.
For example, you may have difficulty judging distances, maintaining balance, or reacting quickly to unexpected situations.
Possible effects include:
Avoid driving, operating heavy machinery, or performing potentially dangerous activities if you experience these symptoms.
If you are taking Kemadrin for the first time, pay attention to how your body responds before performing tasks that require full alertness.
These precautions are particularly important after starting treatment or increasing your dosage.
Contact your healthcare provider if dizziness, vision changes, or difficulty concentrating interferes with your daily activities.
Alcohol may increase certain side effects of Kemadrin, particularly dizziness, impaired concentration, and reduced coordination.
Although a specific interaction between alcohol and procyclidine is not clearly established in all patients, combining them may make it more difficult to remain alert or perform activities safely.
Alcohol can also worsen problems with balance and coordination, which may already affect people with Parkinson’s disease.
For this reason, it is advisable to avoid alcohol or discuss alcohol consumption with your healthcare provider before drinking during treatment.
Possible concerns include increased dizziness, difficulty concentrating, impaired judgment, and a greater risk of falls.
Do not drive or operate machinery after drinking alcohol if you are also taking Kemadrin.
Tell your healthcare provider if you smoke or use tobacco products while taking Kemadrin.
A clinically significant direct interaction between tobacco smoking and procyclidine has not been clearly established.
However, smoking can contribute to dry mouth and other oral health problems.
Because Kemadrin commonly causes dry mouth by reducing saliva production, smoking may make this symptom more uncomfortable.
Reduced saliva can increase the risk of dental cavities, gum irritation, and difficulty swallowing certain foods.
If you experience persistent dry mouth, your healthcare provider may recommend ways to improve oral comfort.
For information about reducing tobacco use, see smoking cessation.
Tell your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding before taking Kemadrin.
The safety of procyclidine during pregnancy has not been adequately established.
Although extensive clinical experience has not shown clear evidence of harm during pregnancy, available research is insufficient to rule out all potential risks.
Your healthcare provider will consider the severity of your movement symptoms and determine whether the expected benefits of treatment outweigh the possible risks to the developing baby.
It is not known whether procyclidine passes into human breast milk.
There is also limited information about its possible effects on breastfed infants.
Because Kemadrin has anticholinergic properties, its potential effects on the infant and milk production should be considered.
Your healthcare provider will assess your treatment needs and determine whether breastfeeding during Kemadrin therapy is appropriate.
Do not start or stop Kemadrin during pregnancy or breastfeeding without consulting your healthcare provider.Â
Older adults may be more sensitive to the anticholinergic effects of Kemadrin.
As people age, changes in medication processing and sensitivity to certain drugs may increase the likelihood of adverse reactions.
Older adults may be particularly susceptible to confusion, hallucinations, memory problems, constipation, and urinary retention.
They may also have a higher risk of falls if the medication causes dizziness or blurred vision.
Your healthcare provider may recommend a lower starting dosage and increase it gradually if necessary.
Important symptoms to monitor include unusual confusion, difficulty urinating, persistent constipation, vision changes, and worsening balance.
Kemadrin is generally used cautiously in older adults because anticholinergic medications can affect memory and thinking.
Your healthcare provider may consider alternative treatments if the risks outweigh the expected benefits.
Kemadrin may reduce the body’s ability to sweat normally.
Sweating helps regulate body temperature by releasing heat through the skin.
Because acetylcholine is involved in stimulating sweat glands, blocking its effects may reduce sweat production.
This can make it more difficult for the body to cool down during hot weather, exercise, or exposure to high temperatures.
Possible symptoms of overheating include:
Avoid prolonged exposure to extreme heat, and maintain adequate hydration unless your healthcare provider has recommended fluid restrictions.
Be particularly cautious when exercising or spending time outdoors during hot weather.
Seek emergency medical attention if you experience a high body temperature accompanied by confusion, fainting, or other symptoms of heatstroke.
Kemadrin should be taken exactly as prescribed by your healthcare provider.
Taking more than the recommended dosage may cause excessive anticholinergic activity, leading to potentially serious complications.
Possible symptoms of an overdose include:
Large overdoses may cause dangerous changes in consciousness, including coma.
If you suspect a Kemadrin overdose, contact a poison control center or seek emergency medical attention immediately.
Do not attempt to treat an overdose at home.
Kemadrin also has the potential for misuse, particularly when taken in higher-than-prescribed doses.
Do not take the medication more frequently or for longer than recommended.
Do not stop taking Kemadrin suddenly without consulting your healthcare provider.
The medication helps control certain movement-related symptoms by reducing acetylcholine activity in the brain.
If treatment is discontinued abruptly, Parkinson’s-related symptoms such as tremors and muscle stiffness may return or become worse.
People taking Kemadrin for drug-induced movement disorders may also experience a return of their original symptoms.
Your healthcare provider may recommend gradually reducing the dosage when treatment is no longer necessary.
The appropriate schedule depends on your medical condition, current dosage, and treatment duration.
Do not increase, decrease, or discontinue Kemadrin without medical advice.
Contact your healthcare provider if you experience persistent dizziness, blurred vision, severe constipation, unusual confusion, hallucinations, or difficulty urinating while taking Kemadrin.
Tell your healthcare provider if you have heart disease, glaucoma, gastrointestinal obstruction, urinary problems, or a history of psychiatric conditions.
Seek urgent medical attention if you develop severe confusion, significant agitation, an inability to urinate, or worsening neurological symptoms.
Seek emergency medical attention if you experience severe eye pain, chest pain, difficulty breathing, symptoms of heatstroke, or a serious allergic reaction.
Kemadrin can help relieve certain symptoms of Parkinson’s disease and medication-induced movement disorders, but careful monitoring is important. Following your prescribed dosage, reviewing medication interactions, and reporting unusual symptoms can help reduce the risk of anticholinergic complications.
Kemadrin may begin relieving certain movement-related symptoms within a few hours after taking a dose. However, the time needed to experience noticeable improvement depends on your medical condition, prescribed dosage, and individual response to treatment. Kemadrin is an anticholinergic medication used to manage symptoms of Parkinson’s disease and certain medication-induced movement disorders. It works by blocking the effects of acetylcholine, a chemical messenger involved in muscle movement and coordination. By reducing acetylcholine activity in specific areas of the brain, Kemadrin may help relieve muscle stiffness, tremors, and involuntary muscle contractions. Some people may notice improvements shortly after starting treatment, particularly when Kemadrin is prescribed for certain medication-induced movement symptoms. For Parkinson’s disease, your healthcare provider may start with a low dosage and gradually increase it over several days to find an appropriate balance between symptom relief and side effects. It may take several days or longer to determine how well the prescribed dosage controls your symptoms. However, Kemadrin does not work equally well for every Parkinson’s symptom. It is generally more helpful for tremors and muscle rigidity than for slowness of movement. Do not increase your Kemadrin dosage if you do not notice immediate improvement. Continue taking the medication as prescribed and contact your healthcare provider if your symptoms remain uncontrolled or become worse.
If you forget to take a dose of Kemadrin, take the missed dose as soon as you remember, unless it is almost time for your next scheduled dose. If your next dose is approaching, skip the missed dose and continue with your regular dosing schedule. Kemadrin is commonly taken several times daily to help control movement-related symptoms. Taking the medication at consistent times helps maintain its effects throughout the day. Missing doses may cause symptoms such as muscle stiffness, tremors, or involuntary movements to become more noticeable. However, do not take two doses together to make up for a missed dose. Taking extra Kemadrin may increase the risk of anticholinergic side effects, including blurred vision, dry mouth, constipation, confusion, rapid heartbeat, and difficulty urinating. If you frequently forget your medication, consider setting reminders or following a consistent daily schedule. Contact your healthcare provider or pharmacist if you miss several doses or are unsure when to resume your medication. Do not change your prescribed dosage without medical advice.
Kemadrin is not generally considered addictive when taken as prescribed. However, procyclidine has the potential for misuse and psychological dependence, particularly when taken in larger amounts than recommended. Some people may experience feelings of euphoria, excitement, or other mood changes when taking excessive doses of Kemadrin. These effects may increase the risk of misuse in susceptible individuals. Although reported cases of Kemadrin misuse are uncommon, taking more than the prescribed amount can cause serious side effects, including confusion, hallucinations, agitation, rapid heartbeat, and difficulty urinating. To reduce these risks, take Kemadrin exactly as directed by your healthcare provider. Do not increase your dosage, take extra tablets, or use the medication more frequently than prescribed. If you have a history of substance use disorder, tell your healthcare provider before starting treatment. You should also avoid stopping Kemadrin suddenly, particularly after prolonged use. Abrupt discontinuation may cause Parkinson’s-related symptoms, including tremors and muscle stiffness, to return or worsen. Your healthcare provider may recommend gradually reducing your dosage when treatment is no longer necessary. If you find yourself wanting to take more Kemadrin than prescribed or experience difficulty controlling your medication use, contact your healthcare provider for guidance.Â
Kemadrin is generally not recommended for children and adolescents because its safety and effectiveness have not been adequately established in these age groups. Kemadrin is primarily prescribed to adults with Parkinson’s disease or certain medication-induced movement disorders. Although children can sometimes develop movement-related side effects from medications, there is limited clinical information about the appropriate use of procyclidine in pediatric patients. Children may also respond differently to anticholinergic medications, which can cause side effects such as dry mouth, blurred vision, constipation, dizziness, and difficulty urinating.Higher doses may increase the risk of more serious symptoms, including confusion, agitation, hallucinations, and an unusually fast heartbeat. The official Kemadrin prescribing information does not recommend routine use in children. It does not establish a standard pediatric dosage or a specific approved minimum age. If a child develops muscle stiffness, tremors, or involuntary muscle contractions after taking another medication, a healthcare provider should assess the cause and recommend an appropriate treatment. Do not give Kemadrin to a child or adolescent unless a specialist has specifically determined that its use is appropriate. Never adjust an adult prescription for a child without medical supervision.Â
| Generic name: | Procyclidine |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 2.5mg, 5mg |
| Quantities Available: | 84, 100 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Kemadrin (procyclidine) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Kemadrin is commonly prescribed in dosages of 2.5 mg or 5 mg, taken three to four times daily. For a 90-day supply, this means you would order up to 360 tablets (90 days x 4 tablets per day).
Yes, we sell procyclidine on our website. You can enjoy low prices when you order through us. To purchase procyclidine, you will need a valid prescription from your healthcare provider. We require this prescription to dispense the medication safely and appropriately. You can submit your prescription by mailing it to us, faxing it, or uploading it through your online account.
Yes, we ship Kemadrin (procyclidine) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Kemadrin (Procyclidine). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Kemadrin (Procyclidine).
REVIEWS